Related Experiment Video
Updated: May 24, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Clinical trials in drug development: a minimalistic approach
1Department Of Medical Oncology, Erasmus University Medical Center-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands. j.verweij@erasmusm.nl
Current Opinion in Oncology
|February 21, 2012
Summary
Oncology drug development is shifting focus to early-stage research, matching patients with targeted therapies. New clinical trial designs aim for faster drug registration with robust early data, potentially bypassing traditional phases.
Area of Science:
- Oncology
- Drug Development
- Clinical Trials
Background:
- Current oncology drug development faces challenges and opportunities.
- There's a need for a system that better matches patients to compounds.
- Emphasis is shifting towards early-stage drug development.
Purpose of the Study:
- To propose a new paradigm for oncology drug development.
- To redefine clinical trial phases and streamline the development process.
- To outline criteria for drug registration based on early-stage data.
Main Methods:
- Redefining clinical phases into 'functional target pharmacology studies' and 'proof of concept studies'.
- Introducing an 'Apollo-capsule' shaped development flow.
- Establishing criteria for drug registration without traditional randomized trials.
Main Results:
- Clinical phases will be restructured, moving away from traditional Phase I, II, and III studies.
- A new development model, the 'Apollo-capsule', is proposed.
- Early development data may support drug registration under specific conditions.
Conclusions:
- Drug registration may proceed without randomized trials if early development criteria are met.
- Key criteria include strong preclinical evidence, predictive biomarkers, high response rates, and minimal safety concerns.
- Post-marketing studies can address concerns related to smaller datasets.
Related Concept Videos
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...